Stockscreener 앱 받기
2.06
10.39%
-0.25
전일 마감가:
$2.31
열려 있는:
$2.35
하루 거래량:
7.02M
Relative Volume:
4.20
시가총액:
$354.93M
수익:
$137.74M
순이익/손실:
$-27.97M
주가수익비율:
-12.88
EPS:
-0.16
순현금흐름:
$-9.61M
1주 성능:
-11.16%
1개월 성능:
-1.43%
6개월 성능:
+16.95%
1년 성능:
-20.69%
1일 변동 폭
$2.0001
$2.3553
1주일 범위
$2.0001
$2.4597
52주 변동 폭
$1.04
$3.93
Heron Therapeutics Inc Stock (HRTX) Company Profile
명칭
Heron Therapeutics Inc
전화
(858) 251-4400
주소
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA
HRTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HRTX
Heron Therapeutics Inc
|
2.06 | 354.93M | 137.74M | -27.97M | -9.61M | -0.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
502.73 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
605.64 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
655.50 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
270.02 | 32.98B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
254.84 | 26.89B | 3.81B | -644.79M | -669.77M | -6.24 |
Heron Therapeutics Inc Stock (HRTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-13 | 개시 | Rodman & Renshaw | Buy |
| 2024-04-23 | 개시 | CapitalOne | Overweight |
| 2024-03-13 | 재확인 | Needham | Buy |
| 2020-05-27 | 개시 | Guggenheim | Buy |
| 2020-02-20 | 재확인 | Needham | Buy |
| 2019-01-16 | 재확인 | Needham | Buy |
| 2018-04-05 | 개시 | Evercore ISI | Outperform |
| 2018-03-19 | 재확인 | Mizuho | Buy |
| 2018-03-01 | 재확인 | Needham | Buy |
| 2018-01-03 | 개시 | Leerink Partners | Outperform |
| 2017-09-27 | 개시 | Northland Capital | Outperform |
| 2017-02-27 | 개시 | Needham | Buy |
| 2016-10-26 | 개시 | Aegis Capital | Buy |
| 2016-09-06 | 재개 | Lake Street | Buy |
| 2016-05-03 | 개시 | Cantor Fitzgerald | Buy |
| 2015-12-10 | 개시 | Lake Street | Buy |
| 2015-09-23 | 재확인 | Leerink Partners | Outperform |
| 2015-09-02 | 개시 | BofA/Merrill | Buy |
| 2015-08-03 | 재확인 | Brean Capital | Buy |
| 2015-06-30 | 재확인 | JMP Securities | Mkt Outperform |
| 2015-06-19 | 재확인 | Leerink Partners | Outperform |
| 2014-08-07 | 개시 | Noble Financial | Buy |
모두보기
Heron Therapeutics Inc 주식(HRTX)의 최신 뉴스
Heron Therapeutics (HRTX) Projected to Post Earnings on Tuesday - MarketBeat
Marshall Wace LLP Sells 698,006 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Purchased by JPMorgan Chase & Co. - MarketBeat
Adage Capital Partners GP L.L.C. Decreases Stake in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Renaissance Technologies LLC Has $1.82 Million Stake in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Heron Therapeutics Inc expected to post a loss of 1 cent a shareEarnings Preview - TradingView
Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Sold by LPL Financial LLC - Defense World
Healthy Upside Potential: Heron Therapeutics Inc (HRTX) - Sete News
American Society of Anesthesiologists Announces Heron Therapeutics as Industry Supporter for Seventh Year | Newswise - Newswise
HRTX stock rated a Buy by Rodman & Renshaw - knoxdaily.com
It would be worthwhile to take a closer look at Heron Therapeutics Inc (HRTX) - uspostnews.com
Heron Therapeutics (HRTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release - Yahoo Finance
Heron Therapeutics Appoints Mark Hensley as COO - TipRanks
Heron Therapeutics Names Mark Hensley as COO - marketscreener.com
Heron Therapeutics Strengthens Leadership: Former Veloxis CEO Takes COO Role with Major Stock Package - Stock Titan
Press Release Distribution & PR Platform - ACCESS Newswire
Heron Therapeutics (NASDAQ:HRTX) Stock Crosses Above 200-Day Moving AverageShould You Sell? - MarketBeat
Geode Capital Management LLC Sells 30,034 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
Investor’s Delight: Heron Therapeutics Inc (HRTX) Closes Strong at 1.88, Up 6.21 - DWinneX
Financial Metrics Exploration: Understanding Heron Therapeutics Inc (HRTX) Through Ratios - DWinneX
The growth track for Heron Therapeutics Inc (HRTX) has changed recently - Sete News
Zacks Industry Outlook Highlights Aurinia Pharmaceuticals, Heron Therapeutics, Esperion Therapeutics, Pyxis Oncology and Plus Therapeutics - Zacks Investment Research
A Closer Look at Heron Therapeutics Inc (HRTX) Stock Gains - investchronicle.com
Is HRTX’s price to cash per share ratio a concern for investors? - uspostnews.com
Heron Therapeutics (NASDAQ:HRTX) Stock Price Passes Above 200-Day Moving Average – Should You Sell? - Defense World
Heron Therapeutics Sets Key Q1 2025 Earnings Date: What Investors Should Watch on May 6 - Stock Titan
Best Momentum Stocks to Buy for April 22nd - TradingView
Are Medical Stocks Lagging Encompass Health (EHC) This Year? - Yahoo Finance
Lacklustre Performance Is Driving Heron Therapeutics, Inc.'s (NASDAQ:HRTX) 26% Price Drop - simplywall.st
Quinn Opportunity Partners LLC Acquires New Position in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Raymond James Financial Inc. Takes $208,000 Position in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Heron Therapeutics (NASDAQ:HRTX) Earns "Buy" Rating from Needham & Company LLC - MarketBeat
Wellington Management Group LLP Sells 8,105 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
Heron Therapeutics’ (HRTX) Buy Rating Reiterated at Needham & Company LLC - Defense World
Raymond James Financial Inc. Takes Position in Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
Needham Keeps Their Buy Rating on Heron Therapeutics (HRTX) - The Globe and Mail
Exploring High Growth Tech Stocks In The US Market April 2025 - Yahoo
Heron Therapeutics, Inc.'s (NASDAQ:HRTX) Path To Profitability - simplywall.st
Heron Therapeutics, Inc. (NASDAQ:HRTX) Position Increased by Charles Schwab Investment Management Inc. - Defense World
Heron Therapeutics Inc (HRTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.27%
0.30%
자본화:
|
볼륨(24시간):